H34.812 vs H34.8121
H34.812 (Central retinal vein occlusion, left eye) compared with H34.8121 (Central retinal vein occlusion, left eye, with retinal neovascularization), from the official CMS tabular data.
Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources
Summary
These codes represent different levels of the same hierarchy: H34.812 is the non-billable header that contains H34.8121, so only H34.8121 (or a sibling) is reported.
Registry fact- What is different?
Title wording and billing status.H34.8121’s title adds “with retinal neovascularization” to the wording the two share (“Central retinal vein occlusion, left eye”). H34.812 is a non-billable header; H34.8121 is billable.
Registry fact
- Can these codes be reported together?
Not as a pair.H34.812 is the non-billable header that contains H34.8121. A header is not reported on a claim, so the choice is H34.8121 or a sibling that matches the documentation.
Registry fact
- Is there an Excludes1 relationship?
None.Neither entry carries an Excludes1 note that names the other code. H34.812 carries 1 Excludes1 note and H34.8121 carries 1 Excludes1 note covering other codes; the side-by-side table quotes them.
Official rule
- Is there an Excludes2 relationship?
None.Neither entry carries an Excludes2 note that names the other code.
Official rule
- Is one more specific?
Yes.H34.8121 is a subdivision of H34.812 in the tabular hierarchy, so it is the more specific of the two.
Registry fact
- Is one a parent or header code?
Yes.H34.812 is the non-billable header that contains H34.8121. A header stands for the whole family beneath it and is not reported on a claim.
Registry fact
- Are there sequencing instructions?
None.Neither entry carries a Code First or Use Additional Code note that names the other.
Official rule
- Are there other coding relationships?
None found.No laterality, encounter-phase, Table of Neoplasms, Table of Drugs and Chemicals, or history-versus-active-disease relationship links these codes.
MedCoder-derived
Official rule: a tabular instructional note or a section of the ICD-10-CM Official Guidelines, quoted as published. Registry fact: the codes’ own published attributes (titles, billable status, position in the hierarchy, code set). MedCoder-derived: a reading MedCoder computes from those facts; it is not itself a rule. How to read the labels
Can these codes be reported together?
Not as a pair — H34.812 is not reportable. H34.812 is the non-billable category that contains H34.8121.
A header stands for the whole family of codes beneath it and is not reported on a claim, so the choice is H34.8121 or a sibling that matches the documentation. No Excludes1/Excludes2 relationship exists between these codes in the official tabular list.
Official guidance behind these answers
Section I.B.2 — Level of Detail in Coding · applies to: H34.812 and H34.8121
Diagnosis codes are to be used and reported at their highest number of characters available and to the highest level of specificity documented in the medical record. ICD-10-CM diagnosis codes are composed of codes with 3, 4, 5, 6 or 7 characters. Codes with three characters are included in ICD-10-CM as the heading of a category of codes that may be further subdivided by the use of fourth and/or fifth characters and/or sixth characters, which provide greater detail. A three-character code is to be used only if it is not further subdivided. A code is invalid if it has not been coded to the full number of characters required for that code, including the 7th character, if applicable.
ICD-10-CM Official Guidelines FY2027
Quoted from the ICD-10-CM Official Guidelines for Coding and Reporting in effect for the release shown. The tabular notes above are the code-level instruction; these sections are the convention that says how such a note is applied. Source document (CMS PDF) · Release and checksum
Side by side
Similar descriptions do not make codes interchangeable. The documentation and the official instructions decide which code applies.
Central retinal vein occlusion, left eye
Central retinal vein occlusion, left eye, with retinal neovascularization
- amaurosis fugax (G45.3)
H34 Retinal vascular occlusions
H00-H59 — Diseases of the Eye and Adnexa (H00-H59)
- One of the following 7th characters is to be assigned to codes in subcategory H34.81 to designate the severity of the occlusion:
No Excludes2, Code first, Use additional code, Code also and Includes note at either code.
Notes are the code’s own tabular entry, quoted as published. A note that names the other code is the one the verdict above rests on. In a row that differs, notes every code shares are dimmed.
Derived from the official CMS ICD-10-CM tabular data (FY2027). A coding-rule comparison, not billing advice: payer-specific edits and medical-necessity policy are outside its scope. All data sources